Modulation by Cytokines of Glucocorticoid Action

• Published in: Annals of the New York Academy of Sciences Vol. 876; no. 1; pp. 210 - 220
• Main Authors: ANGELI, ALBERTO, MASERA, ROSA GABRIELLA, SARTORI, MARIA LUISA, FORTUNATI, NICOLETTA, RACCA, SILVIA, DOVIO, ANDREA, STAURENGHI, ANTONIO, FRAIRIA, ROBERTO
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01-06-1999
• Subjects: Animals; Cytokines - biosynthesis; Cytokines - physiology; Glucocorticoids - biosynthesis; Glucocorticoids - physiology; Humans
• ISSN: 0077-8923; 1749-6632
• DOI: 10.1111/j.1749-6632.1999.tb07641.x

Glucocorticoids (GC) are potent modulators of the inflammatory response. Their effects serve to down‐regulate the inflammatory response and are mediated by genomic pathways that follow the interaction with specific receptors (glucocorticoid receptors, GR). Interleukin (IL)‐1, IL‐2, and IL‐6 are able to increase GC secretion by enhancing synthesis and release of CRH and ACTH. Cytokine effects upon steroidogenesis also occur at the adrenal level. The role of cytokines as modulators of GR has received scarce attention. IL‐1 has been shown to up‐regulate GR mRNA expression in hypothalamic CRH secreting cells. On the other hand, macrophage migration inhibitory factor (MIF), a T‐cell product inducible by inflammatory substances including other cytokines, counterregulates GC action within the immune system. Besides immunocytes and neurons, bone cells are a sensitive target for GC and cytokines. We have found that IL‐2 and IL‐6 up‐regulate remarkably the number of GR binding sites and the expression of GR mRNA in peripheral blood mononuclear cells and in osteoblast‐like Saos‐2 cells. Available data suggest that inflammatory cytokines have both direct and indirect effects on GC action at the target level. Autocrine‐induced transcription of GR in immunocytes and/or osteoblasts could be a mechanism that restrains excess cytokine production.